Compare IFRX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFRX | LFVN |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 62.0M |
| IPO Year | 2017 | 1996 |
| Metric | IFRX | LFVN |
|---|---|---|
| Price | $0.94 | $4.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 216.6K | 112.9K |
| Earning Date | 03-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.77% |
| EPS Growth | N/A | ★ 226.09 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,054.36 | N/A |
| P/E Ratio | ★ N/A | $24.42 |
| Revenue Growth | N/A | ★ 1.86 |
| 52 Week Low | $0.71 | $3.90 |
| 52 Week High | $1.94 | $16.30 |
| Indicator | IFRX | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 42.56 |
| Support Level | $0.77 | $4.32 |
| Resistance Level | $1.16 | $5.32 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 47.91 | 36.82 |
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.